{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T12:14:23Z","timestamp":1698754463514},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2007,10,13]],"date-time":"2007-10-13T00:00:00Z","timestamp":1192233600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1007\/s00393-007-0221-1","type":"journal-article","created":{"date-parts":[[2007,10,11]],"date-time":"2007-10-11T04:43:46Z","timestamp":1192077826000},"page":"573-578","source":"Crossref","is-referenced-by-count":10,"title":["Diagnose und Therapie der Kalziumpyrophosphatkristall-induzierten Arthropathie"],"prefix":"10.1007","volume":"66","author":[{"given":"N.","family":"Announ","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.-A.","family":"Guerne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,10,13]]},"reference":[{"key":"221_CR1","first-page":"557","volume":"124","author":"Gerster","year":"2004","unstructured":"Gerster JC (2004) Chondrocalcinosis: a disease frequently occurring in the second half of life. Rev Med Suisse Romande 124: 557\u2013559","journal-title":"Rev Med Suisse Romande"},{"key":"221_CR2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.cger.2005.02.003","volume":"21","author":"Wise","year":"2005","unstructured":"Wise CM (2005) Crystal-associated arthritis in the elderly. Clin Geriatr Med 21: 491\u2013511","journal-title":"Clin Geriatr Med"},{"key":"221_CR3","first-page":"545","volume":"31","author":"Finck","year":"2004","unstructured":"Finck A, Van Linthoudt D, Duvoisin B (2004) The cervical spine in calcium pyrophosphate dihydrate deposition disease. A prevalent case-control study. J Rheumatol 31: 545\u2013549","journal-title":"J Rheumatol"},{"key":"221_CR4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1055\/s-2003-43228","volume":"7","author":"Bencardino","year":"2003","unstructured":"Bencardino JT, Hassankhani A (2003) Calcium pyrophosphate dihydrate crystal deposition disease. Semin Musculoskelet Radiol 7: 175\u2013185","journal-title":"Semin Musculoskelet Radiol"},{"key":"221_CR5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/ard.2004.024109","volume":"64","author":"Frediani","year":"2005","unstructured":"Frediani B, Filippou G, Falselti P et al. (2005) Diagnosis of calcium pyrophosphate dihydrate crystal deposition disease: ultrasonographic criteria proposed. Ann Rheum Dis 64: 638\u2013640","journal-title":"Ann Rheum Dis"},{"key":"221_CR6","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.rdc.2006.04.001","volume":"32","author":"Choi","year":"2006","unstructured":"Choi MH, Mc Kenzie JD, Dalinka MK (2006) Imaging features of crystal-induced arthropathy. Rheum Dis Clin North Am 32: 427\u2013446","journal-title":"Rheum Dis Clin North Am"},{"key":"221_CR7","doi-asserted-by":"crossref","first-page":"988","DOI":"10.2741\/1593","volume":"10","author":"Johnson","year":"2005","unstructured":"Johnson K, Terkeltaub R (2005) Inorganic pyrophosphate (PPI) in pathologic calcification of articular cartilage. Front Biosci 10: 988\u2013997","journal-title":"Front Biosci"},{"key":"221_CR8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/01.bor.0000218944.89365.dd","volume":"18","author":"Ellman","year":"2006","unstructured":"Ellman MH, Becker MA (2006) Crystal-induced arthropathies: recent investigative advances. Curr Opin Rheumatol 18: 249\u2013255","journal-title":"Curr Opin Rheumatol"},{"key":"221_CR9","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/01.bor.0000157042.19740.f4","volume":"17","author":"Zhang","year":"2005","unstructured":"Zhang Y, Brown MA (2005) Genetic studies of chondrocalcinosis. Curr Opin Rheumatol 17: 330\u2013335","journal-title":"Curr Opin Rheumatol"},{"key":"221_CR10","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/01.bor.0000157041.12116.69","volume":"17","author":"Dalbeth","year":"2005","unstructured":"Dalbeth N, Haskard DO (2005) Inflammation and tissue damage in crystal deposition diseases. Curr Opin Rheumatol 17: 314\u2013318","journal-title":"Curr Opin Rheumatol"},{"key":"221_CR11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"Martinon","year":"2006","unstructured":"Martinon F, Petrilli V, Mayor A et al. (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440: 237\u2013241","journal-title":"Nature"},{"key":"221_CR12","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/01.bor.0000155362.83990.80","volume":"17","author":"Cheung","year":"2005","unstructured":"Cheung HS (2005) Biologic effects of calcium-containing crystals. Curr Opin Rheumatol 17: 336\u2013340","journal-title":"Curr Opin Rheumatol"},{"key":"221_CR13","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/00007890-200103150-00022","volume":"71","author":"Perez-Ruiz","year":"2001","unstructured":"Perez-Ruiz F, Testillano M, Gastaca MA, Herrero-Beites AM (2001) \u201ePseudoseptic\u201c pseudogout associated with hypomagnesemia in liver transplant patients. Transplantation 71: 696\u2013698","journal-title":"Transplantation"},{"key":"221_CR14","doi-asserted-by":"crossref","unstructured":"Timms AE, Sathananthan R, Bradbury L et al. (2002) Genetic testing for haemochromatosis in patients with chondrocalcinosis. Ann Rheum Dis 61: 745\u2013747 (Erratum in: Ann Rheum Dis 2003, 62: 192)","DOI":"10.1136\/ard.61.8.745"},{"key":"221_CR15","doi-asserted-by":"crossref","unstructured":"Pascual E (1999) Management of crystal arthritis. Rheumatology (Oxford) 38: 912\u2013916","DOI":"10.1093\/rheumatology\/38.10.912"},{"key":"221_CR16","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1517\/14656566.6.14.2443","volume":"6","author":"Choy","year":"2005","unstructured":"Choy G (2005) An update on the treatment options for gout and calcium pyrophosphate deposition. Expert Opin Pharmacother 6: 2443\u20132453","journal-title":"Expert Opin Pharmacother"},{"key":"221_CR17","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/art.22389","volume":"56","author":"Chollet-Janin","year":"2007","unstructured":"Chollet-Janin A, Finckh A, Dudler J, Guerne PA (2007) Methotrexate as an alternative therapy for chronic calcium pyrophosphate deposition diseas. An exploratory analysis. Arthritis Rheum 56: 688\u2013692","journal-title":"Arthritis Rheum"},{"key":"221_CR18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/ar419","volume":"4","author":"Chan","year":"2002","unstructured":"Chan ES, Cronstein BN (2002) Molecular action of methotrexate in inflammatory diseases. Arthritis Res 4: 266\u2013273","journal-title":"Arthritis Res"},{"key":"221_CR19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00002281-199905000-00012","volume":"11","author":"Seitz","year":"1999","unstructured":"Seitz M (1999) Molecular and cellular effects of methotrexate. Curr Opin Rheumatol 11: 226\u2013232","journal-title":"Curr Opin Rheumatol"},{"key":"221_CR20","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1136\/pgmj.76.902.787","volume":"76","author":"Hirshberg","year":"2000","unstructured":"Hirshberg B, Muszkat M, Schlesinger O, Rubinow A (2000) Safety of low dose methotrexate in elderly patients with rheumatoid arthritis. Postgrad Med J 76: 787\u2013789","journal-title":"Postgrad Med J"},{"key":"221_CR21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/ard.2004.023408","volume":"64","author":"Yazici","year":"2005","unstructured":"Yazici Y, Sokka T, Kautiainen H et al. (2005) Long term safety of methotrexate in routine clinical care: discontinuation is unusual and rarely the result of laboratory abnormalities. Ann Rheum Dis 64: 207\u2013211","journal-title":"Ann Rheum Dis"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-007-0221-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-007-0221-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-007-0221-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T12:29:40Z","timestamp":1559046580000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-007-0221-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,13]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["221"],"URL":"https:\/\/doi.org\/10.1007\/s00393-007-0221-1","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,13]]}}}